Literature DB >> 12416653

Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes.

Stephen J Fortunato1, Ramkumar Menon.   

Abstract

OBJECTIVE: Endogenous activation of matrix metalloproteinase (MMP) in human fetal membranes is hypothesized to contribute to membrane weakening leading to early rupture and is also involved in the initiation of labor. Our laboratory and several others have studied the source and action of some of these MMPs. The objective of this study is to document the expression pattern of most of the MMPs cloned and sequenced so far in amniochorion during preterm premature rupture of membranes (pPROM), at term not in labor and during term labor.
MATERIALS AND METHODS: Placentas were collected from women with PROM, term not in labor after C-sections and from women after term vaginal delivery. Membranes were separated from the placenta and a section away from the rupture site was selected. Amniochorion were separated from the placenta. RT-PCR was performed to study the expression pattern of MMP15 (MT2-MMP), MMP16 (MT3-MMP), MMP17 (MT4-MMP), MMP18, MMP20, MMP23, MMP24 (MT5-MMP), MMP25 (MT6-MMP), and MMP 26 using specific primers.
RESULTS: A differential pattern of expression was noted for some of the novel MMPs screened in this study in human fetal membranes. mRNA for most of the MMPs were expressed by amniochorion. MMP16 [membrane type metalloproteinase 3], MMP20 [enamelysin], and MMP26 [matrilysin] were not expressed.
CONCLUSION: Amniochorion expresses several of the MMP genes at the time of pPROM, term not in labor and during active labor. We have previously reported the expression pattern of other MMPs and their inhibitors and their potential role in PROM. These findings support our hypothesis that amniochorion has a fully functional MMP system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416653      PMCID: PMC3455681          DOI: 10.1023/a:1020362519981

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  20 in total

Review 1.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

Review 2.  Metalloproteinases and tissue damage.

Authors:  G Murphy; A J Docherty; R M Hembry; J J Reynolds
Journal:  Br J Rheumatol       Date:  1991

3.  MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.

Authors:  S J Fortunato; R Menon; S J Lombardi
Journal:  J Perinat Med       Date:  1999       Impact factor: 1.901

4.  Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes.

Authors:  T M Malak; C D Ockleford; S C Bell; R Dalgleish; N Bright; J Macvicar
Journal:  Placenta       Date:  1993 Jul-Aug       Impact factor: 3.481

5.  Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes.

Authors:  S J Fortunato; R Menon; S J Lombardi
Journal:  Obstet Gynecol       Date:  1999-09       Impact factor: 7.661

6.  Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture.

Authors:  J McLaren; D J Taylor; S C Bell
Journal:  Am J Obstet Gynecol       Date:  2000-02       Impact factor: 8.661

7.  Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes.

Authors:  E Maymon; R Romero; P Pacora; M T Gervasi; K Bianco; F Ghezzi; B H Yoon
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

8.  Collagen content of human amniotic membranes: effect of gestation length and premature rupture.

Authors:  S J Skinner; G A Campos; G C Liggins
Journal:  Obstet Gynecol       Date:  1981-04       Impact factor: 7.661

9.  Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes.

Authors:  D Draper; J McGregor; J Hall; W Jones; M Beutz; R P Heine; R Porreco
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

10.  Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy.

Authors:  Stephen J Fortunato; Bonnie LaFleur; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2003-02       Impact factor: 3.886

View more
  14 in total

Review 1.  Extracellular matrix dynamics and fetal membrane rupture.

Authors:  Jerome F Strauss
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

Review 2.  Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy.

Authors:  Alejandro Majali-Martinez; Ursula Hiden; Nassim Ghaffari-Tabrizi-Wizsy; Uwe Lang; Gernot Desoye; Martina Dieber-Rotheneder
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

3.  The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes.

Authors:  Seung Mi Lee; Roberto Romero; Jeong Woo Park; Sun Min Kim; Chan-Wook Park; Steven J Korzeniewski; Tinnakorn Chaiworapongsa; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-25

4.  Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.

Authors:  Elisabeth I Heath; Barbara A Burtness; Lawrence Kleinberg; Ronald R Salem; Stephen C Yang; Richard F Heitmiller; Marcia I Canto; Jonathan P S Knisely; Mark Topazian; Elizabeth Montgomery; Nancy Tsottles; Yazdi Pithavala; Bridget Rohmiller; Mary Collier; Arlene A Forastiere
Journal:  Invest New Drugs       Date:  2006-03       Impact factor: 3.850

5.  Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency.

Authors:  Kyung Joon Oh; Si Eun Lee; Hanna Jung; Gilja Kim; Roberto Romero; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2010-05       Impact factor: 1.901

6.  Potassium channel modulation by a toxin domain in matrix metalloprotease 23.

Authors:  Srikant Rangaraju; Keith K Khoo; Zhi-Ping Feng; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; Cory Pham; Peter Calabresi; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

Review 7.  Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.

Authors:  Charles A Galea; Hai M Nguyen; K George Chandy; Brian J Smith; Raymond S Norton
Journal:  Cell Mol Life Sci       Date:  2013-08-03       Impact factor: 9.261

8.  Intracellular trafficking of the KV1.3 potassium channel is regulated by the prodomain of a matrix metalloprotease.

Authors:  Hai M Nguyen; Charles A Galea; Galina Schmunk; Brian J Smith; Robert A Edwards; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

9.  Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Steven J Korzeniewski; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-07-31       Impact factor: 3.886

10.  Molecular characterization of porcine MMP19 and MMP23B genes and its association with immune traits.

Authors:  Shuanping Zhao; Yongzhen Zhao; Pengxia Niu; Ning Wang; Zhonglin Tang; Linsen Zan; Kui Li
Journal:  Int J Biol Sci       Date:  2011-09-14       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.